Category: authorship issues

A researcher in Bangladesh who fabricated a list of co-authors — and possibly her data, too — in a paper on dengue fever that was recently retracted has published the same article in a different journal.

In 2019, Farzana Ahmed was a pediatric intensivist at United Hospital Ltd, in Dhaka, when she published a study in the Journal of Bangabandhu Sheikh Mujib Medical University. Titled “Diagnostic value of ferritin for the severity of dengue infection in children,” the article described a study of: 

Continue reading Researcher republishes paper retracted for fake authorship — with a different co-author

There’s an “us” in lupus, but no “we” — at least in the case of a 2020 paper whose list of authors was a fabrication. 

Published in the journal Lupus, the article, “Antibodies to cellular prion protein and its cognate ligand stress-inducible protein 1 in systemic lupus erythematosus,” was written by a group led by Jozélio F Carvalho, a rheumatologist at the University of São Paulo. Or rather, by Carvalho himself. 

According to the notice: 

Continue reading Wait, how did my name end up on that paper?

Just because you work in a lab doesn’t mean you get to call the data you produce your own. Ask Constantin Heil.

In the mid-2010s, Heil was a PhD student at La Sapienza University in Rome, where he conducted studies with his mentor, Giuseppe Giannini. That research led to Heil’s dissertation, a paper titled “One size does not fit all: Cell type specific tailoring of culture conditions permits establishment of divergent stable lines from murine cerebellum.”  

Heil — who is now working in Switzerland for a company called SOPHiA Genetics — used some of those data to publish a 2019 article, “Hedgehog pathway permissive conditions allow generation of immortal cell lines from granule cells derived from cancerous and non-cancerous cerebellum,” in a peer-reviewed journal, Open Biology, which belongs to the Royal Society.

Continue reading There is no I in data: Former grad student has paper retracted after mentor objects

Want to be a first author on a scholarly paper? A Russian company has you covered — starting at about $500. The company claims to have added the names of more than 10,000 researchers to more than 2,000 published articles in scholarly journals over the past three years. Think eBay — or perhaps StubHub — for unscrupulous scientists. 

Although we can’t verify the numbers, at least one major journal indexer, from whom we recently learned of the scheme, is concerned enough about the site that it has demanded that it stop doing business. 

According to the Russian outfit’s site (through Google Translate): 

Continue reading Exclusive: Russian site says it has brokered authorships for more than 10,000 researchers

Retraction Watch readers may have noticed what seems like a growing trend: Co-first authorships. While the move might seem like a way to promote equality, some researchers are worried that it’s having the opposite effect. In response, the Journal of Clinical Investigation (JCI) recently created additional requirements for shared first authorship. We asked Arturo Casadevall, the first author of an editorial describing those changes, to answer a few questions.

Retraction Watch (RW): The title of your editorial, as well as the editorial itself, refers to bias. What kind of bias is of concern when it comes to co-first authors?

Continue reading Sharing the coin of the realm: How one journal hopes new authorship rules will cut down on bias